Aadi Bioscience, Inc. Quarterly Operating Income (Loss) in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Aadi Bioscience, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q2 2024.
  • Aadi Bioscience, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$15.6M, a 20.3% increase year-over-year.
  • Aadi Bioscience, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$70.7M, a 5.66% decline year-over-year.
  • Aadi Bioscience, Inc. annual Operating Income (Loss) for 2023 was -$71.9M, a 14.8% decline from 2022.
  • Aadi Bioscience, Inc. annual Operating Income (Loss) for 2022 was -$62.7M, a 43.6% increase from 2021.
  • Aadi Bioscience, Inc. annual Operating Income (Loss) for 2021 was -$111M, a 4263% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$70.7M -$15.6M +$3.96M +20.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 -$74.6M -$19.5M -$2.69M -16% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 -$71.9M -$17.7M -$2.24M -14.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-13
Q3 2023 -$69.7M -$17.8M -$2.81M -18.7% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 -$66.9M -$19.5M -$1.19M -6.45% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 -$65.7M -$16.8M -$3.01M -21.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 -$62.7M -$15.5M +$473K +2.97% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-13
Q3 2022 -$63.2M -$15M +$72.3M +82.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 -$135M -$18.4M -$14.5M -374% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 -$121M -$13.8M -$9.73M -238% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 -$111M -$15.9M -$10.9M -217% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-29
Q3 2021 -$100M -$87.3M -$84.6M -3179% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$15.7M -$3.88M -$13.1M -142% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 -$2.52M -$4.09M +$27.9K +0.68% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$2.55M -$5.03M -$370K -7.94% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-17
Q3 2020 -$2.18M -$2.66M +$2.3M +46.4% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$4.48M $9.26M +$15.2M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
Q1 2020 -$19.7M -$4.11M +$4.73M +53.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 -$24.4M -$4.66M +$4.21M +47.5% Oct 1, 2019 Dec 31, 2019 10-K 2020-03-16
Q3 2019 -$28.7M -$4.97M -$16.2M -144% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 -$12.5M -$5.98M +$57.5K +0.95% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-12
Q1 2019 -$12.5M -$8.84M -$1.36M -18.3% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 -$11.2M -$8.87M -$2.58M -41% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-16
Q3 2018 -$8.6M $11.2M +$16M Jul 1, 2018 Sep 30, 2018 10-K 2020-03-16
Q2 2018 -$24.6M -$6.04M -$453K -8.11% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-16
Q1 2018 -$24.1M -$7.48M -$2.72M -57.1% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-16
Q4 2017 -$21.4M -$6.29M -$2.98M -90.3% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-07
Q3 2017 -$18.4M -$4.76M -$10.9K -0.23% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-07
Q2 2017 -$18.4M -$5.58M -$1.21M -27.6% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-07
Q1 2017 -$17.2M -$4.76M -$554K -13.2% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-07
Q4 2016 -$16.6M -$3.31M -$16.7M -125% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-15
Q3 2016 $41.8K -$4.75M -$417K -9.64% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-15
Q2 2016 $459K -$4.38M +$726K +14.2% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-15
Q1 2016 -$266K -$4.21M -$243K -6.14% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-15
Q4 2015 -$23K $13.4M +$4.49M +50.5% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-07
Q3 2015 -$4.51M -$4.33M +$437K +9.17% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 -$4.95M -$5.1M -$5.1M Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-15
Q1 2015 $152K -$3.96M +$176K +4.25% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-16
Q4 2014 -$24K $8.88M -$379K -4.09% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-30
Q3 2014 $355K -$4.77M -$290K -6.48% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-13
Q2 2014 $645K -$5.31K* +$149 Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-13
Q1 2014 $645K -$4.14M +$668K +13.9% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-13
Q4 2013 -$22.8K $9.26M -$4.73M -33.8% Oct 1, 2013 Dec 31, 2013 10-K 2015-02-27
Q3 2013 $4.71M -$4.48M +$278K +5.85% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-14
Q2 2013 $4.43M -$5.46K* +$5.03M Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
Q1 2013 -$597K -$4.81M -$575K -13.6% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15
Q4 2012 -$22.4K $14M +$9.74M +229% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-31
Q3 2012 -$9.76M -$4.75M -$4.75M Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q2 2012 -$5.01M -$5.03M -$5.03M Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 $11.4K -$4.23M +$35K +0.82% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q4 2011 -$23.6K $4.25M Oct 1, 2011 Dec 31, 2011 10-K 2013-03-28
Q3 2011 -$5.43K* +$4.23M Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-14
Q2 2011 -$5.86K* +$5.12M Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-14
Q1 2011 -$4.27M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
Q3 2010 -$4.24M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 -$5.12M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.